JP2025513932A5 - - Google Patents
Info
- Publication number
- JP2025513932A5 JP2025513932A5 JP2025504030A JP2025504030A JP2025513932A5 JP 2025513932 A5 JP2025513932 A5 JP 2025513932A5 JP 2025504030 A JP2025504030 A JP 2025504030A JP 2025504030 A JP2025504030 A JP 2025504030A JP 2025513932 A5 JP2025513932 A5 JP 2025513932A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- antisense molecule
- seq
- lmna
- antisense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22165710 | 2022-03-30 | ||
| EP22165710.9 | 2022-03-30 | ||
| PCT/NL2023/050168 WO2023191631A1 (en) | 2022-03-30 | 2023-03-30 | Antisense nucleic acids for use in the treatment for lmna mutation carriers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513932A JP2025513932A (ja) | 2025-04-30 |
| JP2025513932A5 true JP2025513932A5 (https=) | 2026-04-03 |
Family
ID=81074125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025504030A Pending JP2025513932A (ja) | 2022-03-30 | 2023-03-30 | Ｌｍｎａ変異キャリアのための治療における使用のためのアンチセンス核酸 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20260002152A1 (https=) |
| EP (1) | EP4499826A1 (https=) |
| JP (1) | JP2025513932A (https=) |
| KR (1) | KR20250021303A (https=) |
| CN (1) | CN119790153A (https=) |
| AU (1) | AU2023246365A1 (https=) |
| CA (1) | CA3246987A1 (https=) |
| MX (1) | MX2024012034A (https=) |
| WO (1) | WO2023191631A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025096498A1 (en) * | 2023-10-30 | 2025-05-08 | Research Institute At Nationwide Children's Hospital | Compositions and methods for treating diseases or conditions associated with progerin expression |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003070918A2 (en) | 2002-02-20 | 2003-08-28 | Ribozyme Pharmaceuticals, Incorporated | Rna interference by modified short interfering nucleic acid |
| WO2007047913A2 (en) * | 2005-10-20 | 2007-04-26 | Isis Pharmaceuticals, Inc | Compositions and methods for modulation of lmna expression |
| WO2020061497A1 (en) * | 2018-09-20 | 2020-03-26 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulation of lmna expression |
-
2023
- 2023-03-30 CA CA3246987A patent/CA3246987A1/en active Pending
- 2023-03-30 WO PCT/NL2023/050168 patent/WO2023191631A1/en not_active Ceased
- 2023-03-30 US US18/851,915 patent/US20260002152A1/en active Pending
- 2023-03-30 JP JP2025504030A patent/JP2025513932A/ja active Pending
- 2023-03-30 KR KR1020247036183A patent/KR20250021303A/ko active Pending
- 2023-03-30 CN CN202380041546.9A patent/CN119790153A/zh active Pending
- 2023-03-30 EP EP23714866.3A patent/EP4499826A1/en active Pending
- 2023-03-30 AU AU2023246365A patent/AU2023246365A1/en active Pending
-
2024
- 2024-09-27 MX MX2024012034A patent/MX2024012034A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hagan et al. | At least ten genes define the imprinted Dlk1-Dio3 cluster on mouse chromosome 12qF1 | |
| CN103290009B (zh) | 具有促进iNOS mRNA的分解的NO产生抑制活性的正义寡核苷酸以及iNOS产生量的抑制方法 | |
| EP2516647B1 (en) | Molecule for treating an inflammatory disorder | |
| JP2012503493A5 (https=) | ||
| TW202219273A (zh) | 靶向ｒｎａ結合蛋白位點之寡核苷酸 | |
| JP2019500350A (ja) | 結節性硬化症の処置のためのアンチセンスオリゴマー | |
| JP2019500347A5 (https=) | ||
| JP2009537153A5 (https=) | ||
| JP2024531728A5 (https=) | ||
| JPWO2018164275A1 (ja) | アンチセンスオリゴヌクレオチドおよび糖原病Ｉａ型予防または治療用組成物 | |
| JP2025513932A5 (https=) | ||
| JP5759509B2 (ja) | 遺伝子産物のスクリーニング方法 | |
| JP2026002846A (ja) | Ａｎｇｐｔｌ２アンチセンスオリゴヌクレオチドおよびその使用 | |
| CN118019848A (zh) | Rna编辑 | |
| JP7780172B2 (ja) | 筋萎縮性側索硬化症におけるｃｅｐ２９０遺伝子の変異 | |
| JP2700045B2 (ja) | インスリノーマで特異的に発現している遺伝子のコード蛋白質 | |
| US20220290132A1 (en) | Engineered CRISPR/Cas9 Systems for Simultaneous Long-term Regulation of Multiple Targets | |
| WO2010129950A1 (en) | Micro-rna that regulates cardiac remodeling | |
| EP4711455A1 (en) | Small artificial rna (smartrna) oligonucleotide for modulating protein expression | |
| EA050113B1 (ru) | Антисмысловые олигонуклеотиды angptl2 и их применения | |
| WO2026067655A1 (zh) | 调控TAU表达的dsRNA分子 | |
| HK40085514A (en) | Oligonucleotides targeting rna binding protein sites | |
| JP2005021094A (ja) | ＳＭＧ−１特異的ｓｉＲＮＡ及びｍＲＮＡサーベイランス機構抑制剤 |